206 related articles for article (PubMed ID: 22726362)
1. Muscle mitochondria and insulin resistance: a human perspective.
Hoeks J; Schrauwen P
Trends Endocrinol Metab; 2012 Sep; 23(9):444-50. PubMed ID: 22726362
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes mellitus and skeletal muscle metabolic function.
Phielix E; Mensink M
Physiol Behav; 2008 May; 94(2):252-8. PubMed ID: 18342897
[TBL] [Abstract][Full Text] [Related]
3. The role of weight loss and exercise in correcting skeletal muscle mitochondrial abnormalities in obesity, diabetes and aging.
Toledo FG; Goodpaster BH
Mol Cell Endocrinol; 2013 Oct; 379(1-2):30-4. PubMed ID: 23792186
[TBL] [Abstract][Full Text] [Related]
4. Muscular mitochondrial dysfunction and type 2 diabetes mellitus.
Schrauwen-Hinderling VB; Roden M; Kooi ME; Hesselink MK; Schrauwen P
Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):698-703. PubMed ID: 18089950
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol improves insulin resistance of catch-up growth by increasing mitochondrial complexes and antioxidant function in skeletal muscle.
Zheng J; Chen LL; Zhang HH; Hu X; Kong W; Hu D
Metabolism; 2012 Jul; 61(7):954-65. PubMed ID: 22209670
[TBL] [Abstract][Full Text] [Related]
6. Is mitochondrial dysfunction a cause of insulin resistance?
Turner N; Heilbronn LK
Trends Endocrinol Metab; 2008 Nov; 19(9):324-30. PubMed ID: 18804383
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice.
Bonnard C; Durand A; Peyrol S; Chanseaume E; Chauvin MA; Morio B; Vidal H; Rieusset J
J Clin Invest; 2008 Feb; 118(2):789-800. PubMed ID: 18188455
[TBL] [Abstract][Full Text] [Related]
8. Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?
Dumas JF; Simard G; Flamment M; Ducluzeau PH; Ritz P
Diabetes Metab; 2009 Jun; 35(3):159-67. PubMed ID: 19349201
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and mitochondrial function in skeletal muscle.
Dela F; Helge JW
Int J Biochem Cell Biol; 2013 Jan; 45(1):11-5. PubMed ID: 23036788
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle mitochondrial energetics in obesity and type 2 diabetes mellitus: endocrine aspects.
Aguer C; Harper ME
Best Pract Res Clin Endocrinol Metab; 2012 Dec; 26(6):805-19. PubMed ID: 23168281
[TBL] [Abstract][Full Text] [Related]
11. cGMP rescues mitochondrial dysfunction induced by glucose and insulin in myocytes.
Mitsuishi M; Miyashita K; Itoh H
Biochem Biophys Res Commun; 2008 Mar; 367(4):840-5. PubMed ID: 18194668
[TBL] [Abstract][Full Text] [Related]
12. Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes.
van Tienen FH; Praet SF; de Feyter HM; van den Broek NM; Lindsey PJ; Schoonderwoerd KG; de Coo IF; Nicolay K; Prompers JJ; Smeets HJ; van Loon LJ
J Clin Endocrinol Metab; 2012 Sep; 97(9):3261-9. PubMed ID: 22802091
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial oxidative function and type 2 diabetes.
Rabøl R; Boushel R; Dela F
Appl Physiol Nutr Metab; 2006 Dec; 31(6):675-83. PubMed ID: 17213881
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle insulin resistance: role of mitochondria and other ROS sources.
Di Meo S; Iossa S; Venditti P
J Endocrinol; 2017 Apr; 233(1):R15-R42. PubMed ID: 28232636
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content.
Toledo FG; Menshikova EV; Azuma K; Radiková Z; Kelley CA; Ritov VB; Kelley DE
Diabetes; 2008 Apr; 57(4):987-94. PubMed ID: 18252894
[TBL] [Abstract][Full Text] [Related]
16. Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate.
Yan J; Feng Z; Liu J; Shen W; Wang Y; Wertz K; Weber P; Long J; Liu J
J Nutr Biochem; 2012 Jul; 23(7):716-24. PubMed ID: 21820301
[TBL] [Abstract][Full Text] [Related]
17. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance.
Abdul-Ghani MA; Muller FL; Liu Y; Chavez AO; Balas B; Zuo P; Chang Z; Tripathy D; Jani R; Molina-Carrion M; Monroy A; Folli F; Van Remmen H; DeFronzo RA
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E678-85. PubMed ID: 18593850
[TBL] [Abstract][Full Text] [Related]
18. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes.
De Feyter HM; Lenaers E; Houten SM; Schrauwen P; Hesselink MK; Wanders RJ; Nicolay K; Prompers JJ
FASEB J; 2008 Nov; 22(11):3947-55. PubMed ID: 18653763
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial function and insulin resistance during aging: a mini-review.
Phielix E; Szendroedi J; Roden M
Gerontology; 2011; 57(5):387-96. PubMed ID: 20798481
[TBL] [Abstract][Full Text] [Related]
20. Insulin Resistance and Mitochondrial Dysfunction.
Gonzalez-Franquesa A; Patti ME
Adv Exp Med Biol; 2017; 982():465-520. PubMed ID: 28551803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
